Active Ingredient: BLEOMYCIN SULFATE
Proprietary Name: BLEOMYCIN SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 15 UNITS BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A064084
Product Number: 001
Approval Date: Jun 1, 1996
Applicant Holder Full Name: TEVA PARENTERAL MEDICINES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
